Overall Status

Recruiting (17)

Active, not recruiting (5)

Not yet recruiting (3)

Enrolling by invitation (1)

Withdrawn (1)

Phase

phase 2 (8)

n/a (7)

phase 1 (4)

early phase 1 (2)

phase 3 (1)

phase 4 (1)

Collaborator

National Cancer Institute (NCI) (17)

Brander Beacons Cancer Research (1)

Janssen Scientific Affairs, LLC (1)

Oregon Health and Science University (1)

Progenics Pharmaceuticals, Inc. (1)

Radiological Society of North America (1)

Study Documents

Intervention Type

other (16)

drug (13)

procedure (11)

radiation (9)

behavioral (3)

biological (3)

device (1)

genetic (1)

Funder Type

Other (25)

NIH (2)

Study Type

Interventional (23)

Observational (4)

stage iiib prostate cancer ajcc v8

Showing 26 - 27 of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting

Prostate Adenocarcinoma
+5 more

Daratumumab
+2 more

Houston, Texas

M D Anderson Cancer Center

Feb 25, 2022

Pharmacogenomics Testing in Directing Optimal Use of Supportive

Recruiting

Anatomic Stage III Breast Cancer AJCC v8
+45 more

Biospecimen Collection
+3 more

Scottsdale, Arizona

Mayo Clinic in Arizona

Feb 3, 2022